These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9379472)

  • 21. [What is to be done with vancomycin-resistant enterococcal infections?].
    Bonten MJ; Mascini EM; Willems R; Timmer GJ; Gaillard CA; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2545-9. PubMed ID: 11191789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoparcin ban.
    Howarth F; Poulter D
    Vet Rec; 1997 Jan; 140(4):103-4. PubMed ID: 9032915
    [No Abstract]   [Full Text] [Related]  

  • 23. Vancomycin-resistant enterococci in Brooklyn, New York: a moment in time.
    Landman D; Volkert F; Manikal V; Saurina G; Ruan Y; Oydna E; Parola C; Quale J
    Clin Infect Dis; 1999 Dec; 29(6):1587-8. PubMed ID: 10585828
    [No Abstract]   [Full Text] [Related]  

  • 24. From the Centers for Disease Control and Prevention. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994.
    JAMA; 1996 May; 275(18):1397. PubMed ID: 8618356
    [No Abstract]   [Full Text] [Related]  

  • 25. Vancomycin resistant enterococci: impact and management in pediatrics.
    Green M
    Adv Pediatr Infect Dis; 1997; 13():257-77. PubMed ID: 9544315
    [No Abstract]   [Full Text] [Related]  

  • 26. Vancomycin resistance in gram-positive cocci.
    Courvalin P
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enterococcal resistance--an overview.
    Marothi YA; Agnihotri H; Dubey D
    Indian J Med Microbiol; 2005 Oct; 23(4):214-9. PubMed ID: 16327115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to glycopeptides in enterococci.
    Leclercq R; Courvalin P
    Clin Infect Dis; 1997 Apr; 24(4):545-54; quiz 555-6. PubMed ID: 9145724
    [No Abstract]   [Full Text] [Related]  

  • 30. Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil.
    Neves FP; Ribeiro RL; Duarte RS; Teixeira LM; Merquior VL
    Int J Antimicrob Agents; 2009 Mar; 33(3):211-5. PubMed ID: 19010645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of glycopeptide-resistant enterococci by VITEK 2 system and conventional and real-time polymerase chain reaction.
    Eisner A; Gorkiewicz G; Feierl G; Leitner E; Köfer J; Kessler HH; Marth E
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):17-21. PubMed ID: 16182075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital.
    Garnier F; Ducancelle A; Boisset S; Pineiro A; Bergeret M; Denis F; Raymond J
    Int J Antimicrob Agents; 2004 May; 23(5):529-30. PubMed ID: 15120739
    [No Abstract]   [Full Text] [Related]  

  • 33. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use.
    Fishbane S; Cunha BA; Mittal SK; Ruggian J; Shea K; Schoch PE
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):461-2. PubMed ID: 10432156
    [No Abstract]   [Full Text] [Related]  

  • 34. Trimethoprim resistance genes in vancomycin-resistant Enterococcus faecium clinical isolates from France.
    Cattoir V; Huynh TM; Bourdon N; Auzou M; Leclercq R
    Int J Antimicrob Agents; 2009 Oct; 34(4):390-2. PubMed ID: 19619988
    [No Abstract]   [Full Text] [Related]  

  • 35. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin-resistant enterococci.
    Moellering RC
    Clin Infect Dis; 1998 May; 26(5):1196-9. PubMed ID: 9597252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
    Chien JW; Kucia ML; Salata RA
    Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin-resistant enterococci. Mechanism and clinical relevance.
    Eliopoulos GM
    Infect Dis Clin North Am; 1997 Dec; 11(4):851-65. PubMed ID: 9421703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulase-negative staphylococcus and enterococcus as predominant pathogens in liver transplant recipients with Gram-positive coccal bacteremia.
    Shi SH; Kong HS; Jia CK; Xu J; Zhang WJ; Wang WL; Shen Y; Zhang M; Zheng SS
    Chin Med J (Engl); 2010 Aug; 123(15):1983-8. PubMed ID: 20819529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Control of vancomycin resistant enterococcus and methicillin resistant staphylococcus aureus bacteria gaining every day].
    Pilon PA
    Perspect Infirm; 2003; 1(1):25-6. PubMed ID: 14705334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.